Home > Press Releases > Medical Imaging AI Market

Medical Imaging AI Market Likely to Reach ~USD 5 billion by 2035

Report Code: HC-72109  |  Published in: Apr 2026, By MarketGenics  |  Number of pages: 290

Global Medical Imaging AI Market Forecast 2035:

According to the report, the global medical imaging AI market is likely to grow from USD 0.8 Billion in 2025 to USD 4.6 Billion in 2035 at a highest CAGR of 19.4% during the time period. The entire medical imaging AI market is experiencing strong growth because diagnostic imaging procedures are increasing and healthcare digitalization is becoming more common and people need better methods to identify diseases at earlier stages. Healthcare providers are using AI-enabled imaging solutions to automate their image analysis process which results in better diagnostic accuracy and decreases the work demands on their medical staff thus improving operational efficiency and patient health results.

Government initiatives that back digital health systems and AI technology implementation are driving faster digital health adoption rates in both developed nations and emerging markets. The healthcare sector uses medical imaging AI across various applications which include optimizing radiology workflows and detecting oncology cases and assessing cardiovascular risk. The combination of deep learning technology with cloud computing and sophisticated analytics tools results in better medical image analysis and improved decision-making for clinical purposes.

AI technology allows medical professionals to perform real-time assessment and case priority determination of urgent medical situations while its growing adoption in neurology and pulmonology fields is broadening its application in medical practice. Cloud-based and interoperable imaging platforms are expanding their market reach through the development of new scalable solutions which hospitals and diagnostic networks can implement.                                         

Key Driver, Restraint, and Growth Opportunity Shaping the Global Medical Imaging AI Market

The worldwide medical imaging AI market experiences growth because healthcare organizations use artificial intelligence technology to automate image analysis in their radiology and clinical diagnostic procedures which results in shorter processing times and more accurate diagnostic results. Healthcare organizations use AI solutions to optimize their operations while implementing healthcare detection and stroke recognition and procedure management systems which results in better patient care.

RadNet Inc. introduced machine learning imaging technology through its DeepHealth division which allows its entire network to conduct more advanced breast cancer assessments and risk evaluations.

The process of maintaining consistent performance across multiple imaging data sets faces obstacles because of differences in imaging equipment and imaging procedures and patient demographic information. AI systems depend on quality data to function correctly which creates difficulties because low-quality scans and non-standardized data require complete testing and medical expert supervision.

The implementation process becomes more expensive due to these complicated matters which also restrict the ability of smaller healthcare organizations to expand their operations because they lack advanced technological systems.

The use of artificial intelligence in preventive and precision medicine presents a major opportunity because imaging artificial intelligence technology enables healthcare providers to identify diseases at an initial stage while developing tailored treatment strategies.

The Tempus organization expanded its AI-powered diagnostic system in 2025 to connect imaging information with both clinical data and genomic information which enables healthcare professionals to deliver more personalized treatment across oncology and other medical fields.

Impact of Global Tariff Policies on the Medical Imaging AI Market Growth and Strategy

The medical imaging AI market experiences growth through tighter regulatory requirements and data governance rules which control the process of acquiring data and developing and implementing AI systems in medical environments. AI solution providers must comply with stringent standards related to patient data privacy, clinical validation, and interoperability, particularly across regions such as North America, Europe, and Asia Pacific.

The companies need to change their product development and product launch methods because they must follow different rules in different countries while making their products available throughout the world. The rising compliance costs together with the extended approval timelines which result from new regulations that authorities such as the U.S. Food and Drug Administration and European regulatory bodies established, create additional operational challenges for AI developers.

The presence of these challenges creates higher solution costs for healthcare providers, which results in slower implementation processes that especially affect smaller hospitals and diagnostic centers, while the new AI imaging tools face delays in innovation and commercialization.

National programs provide funding to support government efforts which establish local healthcare innovation and build digital health ecosystems. The efforts focus on building domestic AI capabilities while protecting data sovereignty and creating secure health data systems, which lead to medical imaging AI market development in the region. The system helps organizations build market strength by reducing their dependence on foreign technologies and establishing a stable foundation through regulatory challenges.

Expansion of Global Medical Imaging AI Market

Technological Advancements, Rising Diagnostic Demand, and Healthcare Digitalization Driving the Global Medical Imaging AI Market Expansion

  • The global medical imaging AI market experiences rapid growth because of ongoing technological progress and increased demand for diagnostic services and the fast-paced adoption of digital healthcare solutions. Deep learning technology together with generative AI and cloud-based imaging systems, create new possibilities for better and quicker image reading results which help doctors make clinical decisions. The development of cloud-based imaging systems through Konica Minolta's Exa Enterprise platform shows how adaptable and system-integrated solutions improve operational processes and distance medical assessments.
  • The rising number of people with chronic illnesses and the higher demand for medical imaging services both create greater need for automatic diagnostic systems which help doctors by decreasing their tasks and enabling faster result delivery. AI systems detect advanced patterns which humans cannot see, thus they aid in the early identification of diseases and development of tailored medical treatments.
  • Healthcare digitalization proceeds to increase adoption rates which are supported by substantial funding and partnerships between organizations. The acquisition of Intelerad by GE HealthCare Technologies Inc. demonstrates their intention to enhance cloud-based imaging and AI capabilities which shows a trend towards software-based healthcare systems that use data as their primary resource.
  • The global medical imaging AI market experiences continuous expansion because advanced AI technology and rising diagnostic requirements and developing digital systems present multiple opportunities for medical imaging AI market.

Regional Analysis of Global Medical Imaging AI Market

  • North America shows the greatest need in medical imaging AI market its healthcare system operates at advanced levels and its medical facilities have adopted digital imaging technologies and its payment systems function efficiently. The region faces a high demand for medical imaging services because of its population who suffer from chronic illnesses which require regular medical examination and its healthcare facilities which use artificial intelligence technology for their radiology operations.
  • North America maintains its worldwide market leadership because of its major companies like GE HealthCare Technologies Inc. and Siemens Healthineers AG who invest heavily in artificial intelligence diagnostic technologies and cloud-based medical imaging solutions. The medical imaging AI market in Asia Pacific experiences its fastest growth because of the region's quick adoption of digital healthcare technologies and its growing understanding of the benefits of early disease identification and its increasing availability of diagnostic services in developing countries.
  • The governments of India and China are creating a supportive environment for AI-based imaging technologies through their healthcare system improvements and financial backing of medical infrastructure projects. The region will experience double-digit growth because of digital health initiatives and the rise of low-cost imaging solutions and partnerships between local startups and international companies.

Prominent players operating in global medical imaging AI market include prominent companies such as Aidoc, Arterys, Inc., Butterfly Network, Inc., Canon Medical Systems Corporation, Digital Diagnostics Inc., Enlitic, Inc., GE HealthCare Technologies Inc., Google LLC, HeartFlow, Inc., iCAD, Inc., Infervision, International Business Machines Corporation (IBM), Koninklijke Philips N.V., Lunit Inc., Microsoft Corporation, Qure.ai, Siemens Healthineers AG, Tempus AI, Inc., Viz.ai, Inc., Zebra Medical Vision, along with several other key players.

The global medical imaging AI market has been segmented as follows:

Global Medical Imaging AI Market Analysis, by Component

  • Software
    • AI Algorithms & Models
    • Deep Learning Models
    • Machine Learning Models
    • Others
    • Image Analysis Software
    • Detection Software
    • Diagnosis Support Software
    • Segmentation & Quantification Tools
    • Others
    • Visualization & Reporting Software
    • 3D Visualization Tools
    • Automated Reporting Solutions
    • Others
    • Workflow Management Software
    • Triage & Prioritization Tools
    • PACS/RIS Integration Software
    • Others
    • Data Management Software
    • Image Data Platforms
    • Annotation Tools
    • Data Labeling Software
    • Others
  • Hardware
    • Processing Units
    • GPUs (Graphics Processing Units)
    • CPUs (Central Processing Units)
    • Edge AI Processors
    • Others
    • Imaging Hardware Integration Components
    • AI-enabled CT Systems
    • AI-enabled MRI Systems
    • AI-enabled X-ray & Ultrasound Devices
    • Others
    • Storage Infrastructure
    • On-premise Servers
    • High-performance Storage Systems
    • Others
  • Services
    • Professional Services
    • Consulting Services
    • Integration & Deployment Services
    • Training & Education
    • Others
    • Support & Maintenance Services
    • Technical Support
    • Software Updates & Upgrades
    • Others
    • Managed Services
    • AI-as-a-Service (AIaaS)
    • Remote Monitoring & Management
    • Others
    • Data Services
    • Data Annotation & Labeling Services
    • Dataset Curation & Management
    • Others

Global Medical Imaging AI Market Analysis, by Deployment Mode

  • Cloud-based
  • On-premises
  • Hybrid

Global Medical Imaging AI Market Analysis, by Imaging Modality

  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • X-ray
  • Ultrasound
  • Nuclear Imaging (PET/SPECT)
  • Mammography
  • Others

Global Medical Imaging AI Market Analysis, by Technology

  • Machine Learning
  • Deep Learning
  • Natural Language Processing (NLP)
  • Computer Vision
  • Others

Global Medical Imaging AI Market Analysis, by Workflow Stage

  • Image Acquisition
  • Image Processing & Analysis
  • Reporting & Communication
  • Data Storage & Management
  • Others

Global Medical Imaging AI Market Analysis, by Functionality

  • Computer-Aided Detection (CADe)
  • Computer-Aided Diagnosis (CADx)
  • Image Quantification & Measurement
  • Workflow Optimization & Triage
  • Predictive Analytics
  • Others

Global Medical Imaging AI Market Analysis, by Clinical Setting

  • Emergency Care
  • Routine Diagnostics
  • Screening Programs
  • Intensive Care Units (ICU)
  • Others

Global Medical Imaging AI Market Analysis, by Application

  • Neurology
  • Cardiology
  • Oncology
  • Orthopedics
  • Pulmonology
  • Breast Imaging
  • Gastroenterology
  • Others

Global Medical Imaging AI Market Analysis, by End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Research & Academic Institutes
  • Others

Global Medical Imaging AI Market Analysis, by Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Natures
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Natures
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Medical Imaging AI Market Outlook
      • 2.1.1. Medical Imaging AI Market Size (Value - US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Industry Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising imaging volumes and demand for faster, more accurate diagnostics are accelerating adoption of AI-enabled imaging solutions.
        • 4.1.1.2. Advancements in deep learning and cloud-based platforms are enhancing image analysis, workflow efficiency, and clinical decision-making.
        • 4.1.1.3. Increasing healthcare digitalization and supportive regulatory approvals are driving integration of AI into radiology practices.
      • 4.1.2. Restraints
        • 4.1.2.1. High implementation and integration costs limit adoption, especially among small and mid-sized healthcare providers.
        • 4.1.2.2. Lack of trust in AI outputs and concerns over algorithm transparency hinder widespread clinical acceptance.
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Value Chain Analysis
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Medical Imaging AI Market Demand
      • 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Medical Imaging AI Market Analysis, by Component
    • 6.1. Key Segment Analysis
    • 6.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Component, 2021-2035
      • 6.2.1. Software
        • 6.2.1.1. AI Algorithms & Models
          • 6.2.1.1.1. Deep Learning Models
          • 6.2.1.1.2. Machine Learning Models
          • 6.2.1.1.3. Others
        • 6.2.1.2. Image Analysis Software
          • 6.2.1.2.1. Detection Software
          • 6.2.1.2.2. Diagnosis Support Software
          • 6.2.1.2.3. Segmentation & Quantification Tools
          • 6.2.1.2.4. Others
        • 6.2.1.3. Visualization & Reporting Software
          • 6.2.1.3.1. 3D Visualization Tools
          • 6.2.1.3.2. Automated Reporting Solutions
          • 6.2.1.3.3. Others
        • 6.2.1.4. Workflow Management Software
          • 6.2.1.4.1. Triage & Prioritization Tools
          • 6.2.1.4.2. PACS/RIS Integration Software
          • 6.2.1.4.3. Others
        • 6.2.1.5. Data Management Software
          • 6.2.1.5.1. Image Data Platforms
          • 6.2.1.5.2. Annotation Tools
          • 6.2.1.5.3. Data Labeling Software
          • 6.2.1.5.4. Others
      • 6.2.2. Hardware
        • 6.2.2.1. Processing Units
          • 6.2.2.1.1. GPUs (Graphics Processing Units)
          • 6.2.2.1.2. CPUs (Central Processing Units)
          • 6.2.2.1.3. Edge AI Processors
          • 6.2.2.1.4. Others
        • 6.2.2.2. Imaging Hardware Integration Components
          • 6.2.2.2.1. AI-enabled CT Systems
          • 6.2.2.2.2. AI-enabled MRI Systems
          • 6.2.2.2.3. AI-enabled X-ray & Ultrasound Devices
          • 6.2.2.2.4. Others
        • 6.2.2.3. Storage Infrastructure
          • 6.2.2.3.1. On-premise Servers
          • 6.2.2.3.2. High-performance Storage Systems
          • 6.2.2.3.3. Others
      • 6.2.3. Services
        • 6.2.3.1. Professional Services
          • 6.2.3.1.1. Consulting Services
          • 6.2.3.1.2. Integration & Deployment Services
          • 6.2.3.1.3. Training & Education
          • 6.2.3.1.4. Others
        • 6.2.3.2. Support & Maintenance Services
          • 6.2.3.2.1. Technical Support
          • 6.2.3.2.2. Software Updates & Upgrades
          • 6.2.3.2.3. Others
        • 6.2.3.3. Managed Services
          • 6.2.3.3.1. AI-as-a-Service (AIaaS)
          • 6.2.3.3.2. Remote Monitoring & Management
          • 6.2.3.3.3. Others
        • 6.2.3.4. Data Services
          • 6.2.3.4.1. Data Annotation & Labeling Services
          • 6.2.3.4.2. Dataset Curation & Management
          • 6.2.3.4.3. Others
  • 7. Global Medical Imaging AI Market Analysis, by Deployment Mode
    • 7.1. Key Segment Analysis
    • 7.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Deployment Mode, 2021-2035
      • 7.2.1. Cloud-based
      • 7.2.2. On-premises
      • 7.2.3. Hybrid
  • 8. Global Medical Imaging AI Market Analysis, by Imaging Modality
    • 8.1. Key Segment Analysis
    • 8.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Imaging Modality, 2021-2035
      • 8.2.1. Computed Tomography (CT)
      • 8.2.2. Magnetic Resonance Imaging (MRI)
      • 8.2.3. X-ray
      • 8.2.4. Ultrasound
      • 8.2.5. Nuclear Imaging (PET/SPECT)
      • 8.2.6. Mammography
      • 8.2.7. Others
  • 9. Global Medical Imaging AI Market Analysis, by Technology
    • 9.1. Key Segment Analysis
    • 9.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
      • 9.2.1. Machine Learning
      • 9.2.2. Deep Learning
      • 9.2.3. Natural Language Processing (NLP)
      • 9.2.4. Computer Vision
      • 9.2.5. Others
  • 10. Global Medical Imaging AI Market Analysis, by Workflow Stage
    • 10.1. Key Segment Analysis
    • 10.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Workflow Stage, 2021-2035
      • 10.2.1. Image Acquisition
      • 10.2.2. Image Processing & Analysis
      • 10.2.3. Reporting & Communication
      • 10.2.4. Data Storage & Management
      • 10.2.5. Others
  • 11. Global Medical Imaging AI Market Analysis, by Functionality
    • 11.1. Key Segment Analysis
    • 11.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Functionality, 2021-2035
      • 11.2.1. Computer-Aided Detection (CADe)
      • 11.2.2. Computer-Aided Diagnosis (CADx)
      • 11.2.3. Image Quantification & Measurement
      • 11.2.4. Workflow Optimization & Triage
      • 11.2.5. Predictive Analytics
      • 11.2.6. Others
  • 12. Global Medical Imaging AI Market Analysis, by Clinical Setting
    • 12.1. Key Segment Analysis
    • 12.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Clinical Setting, 2021-2035
      • 12.2.1. Emergency Care
      • 12.2.2. Routine Diagnostics
      • 12.2.3. Screening Programs
      • 12.2.4. Intensive Care Units (ICU)
      • 12.2.5. Others
  • 13. Global Medical Imaging AI Market Analysis, by Application
    • 13.1. Key Segment Analysis
    • 13.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
      • 13.2.1. Neurology
      • 13.2.2. Cardiology
      • 13.2.3. Oncology
      • 13.2.4. Orthopedics
      • 13.2.5. Pulmonology
      • 13.2.6. Breast Imaging
      • 13.2.7. Gastroenterology
      • 13.2.8. Others
  • 14. Global Medical Imaging AI Market Analysis, by End User
    • 14.1. Key Segment Analysis
    • 14.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
      • 14.2.1. Hospitals
      • 14.2.2. Diagnostic Imaging Centers
      • 14.2.3. Ambulatory Surgical Centers
      • 14.2.4. Research & Academic Institutes
      • 14.2.5. Others
  • 15. Global Medical Imaging AI Market Analysis and Forecasts, by Region
    • 15.1. Key Findings
    • 15.2. Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 15.2.1. North America
      • 15.2.2. Europe
      • 15.2.3. Asia Pacific
      • 15.2.4. Middle East
      • 15.2.5. Africa
      • 15.2.6. South America
  • 16. North America Medical Imaging AI Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. North America Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Component
      • 16.3.2. Deployment Mode
      • 16.3.3. Imaging Modality
      • 16.3.4. Technology
      • 16.3.5. Workflow Stage
      • 16.3.6. Functionality
      • 16.3.7. Clinical Setting
      • 16.3.8. Application
      • 16.3.9. End User
      • 16.3.10. Country
        • 16.3.10.1. USA
        • 16.3.10.2. Canada
        • 16.3.10.3. Mexico
    • 16.4. USA Medical Imaging AI Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Component
      • 16.4.3. Deployment Mode
      • 16.4.4. Imaging Modality
      • 16.4.5. Technology
      • 16.4.6. Workflow Stage
      • 16.4.7. Functionality
      • 16.4.8. Clinical Setting
      • 16.4.9. Application
      • 16.4.10. End User
    • 16.5. Canada Medical Imaging AI Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Component
      • 16.5.3. Deployment Mode
      • 16.5.4. Imaging Modality
      • 16.5.5. Technology
      • 16.5.6. Workflow Stage
      • 16.5.7. Functionality
      • 16.5.8. Clinical Setting
      • 16.5.9. Application
      • 16.5.10. End User
    • 16.6. Mexico Medical Imaging AI Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Component
      • 16.6.3. Deployment Mode
      • 16.6.4. Imaging Modality
      • 16.6.5. Technology
      • 16.6.6. Workflow Stage
      • 16.6.7. Functionality
      • 16.6.8. Clinical Setting
      • 16.6.9. Application
      • 16.6.10. End User
  • 17. Europe Medical Imaging AI Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Europe Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Component
      • 17.3.2. Deployment Mode
      • 17.3.3. Imaging Modality
      • 17.3.4. Technology
      • 17.3.5. Workflow Stage
      • 17.3.6. Functionality
      • 17.3.7. Clinical Setting
      • 17.3.8. Application
      • 17.3.9. End User
      • 17.3.10. Country
        • 17.3.10.1. Germany
        • 17.3.10.2. United Kingdom
        • 17.3.10.3. France
        • 17.3.10.4. Italy
        • 17.3.10.5. Spain
        • 17.3.10.6. Netherlands
        • 17.3.10.7. Nordic Countries
        • 17.3.10.8. Poland
        • 17.3.10.9. Russia & CIS
        • 17.3.10.10. Rest of Europe
    • 17.4. Germany Medical Imaging AI Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Component
      • 17.4.3. Deployment Mode
      • 17.4.4. Imaging Modality
      • 17.4.5. Technology
      • 17.4.6. Workflow Stage
      • 17.4.7. Functionality
      • 17.4.8. Clinical Setting
      • 17.4.9. Application
      • 17.4.10. End User
    • 17.5. United Kingdom Medical Imaging AI Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Component
      • 17.5.3. Deployment Mode
      • 17.5.4. Imaging Modality
      • 17.5.5. Technology
      • 17.5.6. Workflow Stage
      • 17.5.7. Functionality
      • 17.5.8. Clinical Setting
      • 17.5.9. Application
      • 17.5.10. End User
    • 17.6. France Medical Imaging AI Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Component
      • 17.6.3. Deployment Mode
      • 17.6.4. Imaging Modality
      • 17.6.5. Technology
      • 17.6.6. Workflow Stage
      • 17.6.7. Functionality
      • 17.6.8. Clinical Setting
      • 17.6.9. Application
      • 17.6.10. End User
    • 17.7. Italy Medical Imaging AI Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Component
      • 17.7.3. Deployment Mode
      • 17.7.4. Imaging Modality
      • 17.7.5. Technology
      • 17.7.6. Workflow Stage
      • 17.7.7. Functionality
      • 17.7.8. Clinical Setting
      • 17.7.9. Application
      • 17.7.10. End User
    • 17.8. Spain Medical Imaging AI Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Component
      • 17.8.3. Deployment Mode
      • 17.8.4. Imaging Modality
      • 17.8.5. Technology
      • 17.8.6. Workflow Stage
      • 17.8.7. Functionality
      • 17.8.8. Clinical Setting
      • 17.8.9. Application
      • 17.8.10. End User
    • 17.9. Netherlands Medical Imaging AI Market
      • 17.9.1. Country Segmental Analysis
      • 17.9.2. Component
      • 17.9.3. Deployment Mode
      • 17.9.4. Imaging Modality
      • 17.9.5. Technology
      • 17.9.6. Workflow Stage
      • 17.9.7. Functionality
      • 17.9.8. Clinical Setting
      • 17.9.9. Application
      • 17.9.10. End User
    • 17.10. Nordic Countries Medical Imaging AI Market
      • 17.10.1. Country Segmental Analysis
      • 17.10.2. Component
      • 17.10.3. Deployment Mode
      • 17.10.4. Imaging Modality
      • 17.10.5. Technology
      • 17.10.6. Workflow Stage
      • 17.10.7. Functionality
      • 17.10.8. Clinical Setting
      • 17.10.9. Application
      • 17.10.10. End User
    • 17.11. Poland Medical Imaging AI Market
      • 17.11.1. Country Segmental Analysis
      • 17.11.2. Component
      • 17.11.3. Deployment Mode
      • 17.11.4. Imaging Modality
      • 17.11.5. Technology
      • 17.11.6. Workflow Stage
      • 17.11.7. Functionality
      • 17.11.8. Clinical Setting
      • 17.11.9. Application
      • 17.11.10. End User
    • 17.12. Russia & CIS Medical Imaging AI Market
      • 17.12.1. Country Segmental Analysis
      • 17.12.2. Component
      • 17.12.3. Deployment Mode
      • 17.12.4. Imaging Modality
      • 17.12.5. Technology
      • 17.12.6. Workflow Stage
      • 17.12.7. Functionality
      • 17.12.8. Clinical Setting
      • 17.12.9. Application
      • 17.12.10. End User
    • 17.13. Rest of Europe Medical Imaging AI Market
      • 17.13.1. Country Segmental Analysis
      • 17.13.2. Component
      • 17.13.3. Deployment Mode
      • 17.13.4. Imaging Modality
      • 17.13.5. Technology
      • 17.13.6. Workflow Stage
      • 17.13.7. Functionality
      • 17.13.8. Clinical Setting
      • 17.13.9. Application
      • 17.13.10. End User
  • 18. Asia Pacific Medical Imaging AI Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Asia Pacific Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Component
      • 18.3.2. Deployment Mode
      • 18.3.3. Imaging Modality
      • 18.3.4. Technology
      • 18.3.5. Workflow Stage
      • 18.3.6. Functionality
      • 18.3.7. Clinical Setting
      • 18.3.8. Application
      • 18.3.9. End User
      • 18.3.10. Country
        • 18.3.10.1. China
        • 18.3.10.2. India
        • 18.3.10.3. Japan
        • 18.3.10.4. South Korea
        • 18.3.10.5. Australia and New Zealand
        • 18.3.10.6. Indonesia
        • 18.3.10.7. Malaysia
        • 18.3.10.8. Thailand
        • 18.3.10.9. Vietnam
        • 18.3.10.10. Rest of Asia Pacific
    • 18.4. China Medical Imaging AI Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Component
      • 18.4.3. Deployment Mode
      • 18.4.4. Imaging Modality
      • 18.4.5. Technology
      • 18.4.6. Workflow Stage
      • 18.4.7. Functionality
      • 18.4.8. Clinical Setting
      • 18.4.9. Application
      • 18.4.10. End User
    • 18.5. India Medical Imaging AI Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Component
      • 18.5.3. Deployment Mode
      • 18.5.4. Imaging Modality
      • 18.5.5. Technology
      • 18.5.6. Workflow Stage
      • 18.5.7. Functionality
      • 18.5.8. Clinical Setting
      • 18.5.9. Application
      • 18.5.10. End User
    • 18.6. Japan Medical Imaging AI Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Component
      • 18.6.3. Deployment Mode
      • 18.6.4. Imaging Modality
      • 18.6.5. Technology
      • 18.6.6. Workflow Stage
      • 18.6.7. Functionality
      • 18.6.8. Clinical Setting
      • 18.6.9. Application
      • 18.6.10. End User
    • 18.7. South Korea Medical Imaging AI Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Component
      • 18.7.3. Deployment Mode
      • 18.7.4. Imaging Modality
      • 18.7.5. Technology
      • 18.7.6. Workflow Stage
      • 18.7.7. Functionality
      • 18.7.8. Clinical Setting
      • 18.7.9. Application
      • 18.7.10. End User
    • 18.8. Australia and New Zealand Medical Imaging AI Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Component
      • 18.8.3. Deployment Mode
      • 18.8.4. Imaging Modality
      • 18.8.5. Technology
      • 18.8.6. Workflow Stage
      • 18.8.7. Functionality
      • 18.8.8. Clinical Setting
      • 18.8.9. Application
      • 18.8.10. End User
    • 18.9. Indonesia Medical Imaging AI Market
      • 18.9.1. Country Segmental Analysis
      • 18.9.2. Component
      • 18.9.3. Deployment Mode
      • 18.9.4. Imaging Modality
      • 18.9.5. Technology
      • 18.9.6. Workflow Stage
      • 18.9.7. Functionality
      • 18.9.8. Clinical Setting
      • 18.9.9. Application
      • 18.9.10. End User
    • 18.10. Malaysia Medical Imaging AI Market
      • 18.10.1. Country Segmental Analysis
      • 18.10.2. Component
      • 18.10.3. Deployment Mode
      • 18.10.4. Imaging Modality
      • 18.10.5. Technology
      • 18.10.6. Workflow Stage
      • 18.10.7. Functionality
      • 18.10.8. Clinical Setting
      • 18.10.9. Application
      • 18.10.10. End User
    • 18.11. Thailand Medical Imaging AI Market
      • 18.11.1. Country Segmental Analysis
      • 18.11.2. Component
      • 18.11.3. Deployment Mode
      • 18.11.4. Imaging Modality
      • 18.11.5. Technology
      • 18.11.6. Workflow Stage
      • 18.11.7. Functionality
      • 18.11.8. Clinical Setting
      • 18.11.9. Application
      • 18.11.10. End User
    • 18.12. Vietnam Medical Imaging AI Market
      • 18.12.1. Country Segmental Analysis
      • 18.12.2. Component
      • 18.12.3. Deployment Mode
      • 18.12.4. Imaging Modality
      • 18.12.5. Technology
      • 18.12.6. Workflow Stage
      • 18.12.7. Functionality
      • 18.12.8. Clinical Setting
      • 18.12.9. Application
      • 18.12.10. End User
    • 18.13. Rest of Asia Pacific Medical Imaging AI Market
      • 18.13.1. Country Segmental Analysis
      • 18.13.2. Component
      • 18.13.3. Deployment Mode
      • 18.13.4. Imaging Modality
      • 18.13.5. Technology
      • 18.13.6. Workflow Stage
      • 18.13.7. Functionality
      • 18.13.8. Clinical Setting
      • 18.13.9. Application
      • 18.13.10. End User
  • 19. Middle East Medical Imaging AI Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. Middle East Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Component
      • 19.3.2. Deployment Mode
      • 19.3.3. Imaging Modality
      • 19.3.4. Technology
      • 19.3.5. Workflow Stage
      • 19.3.6. Functionality
      • 19.3.7. Clinical Setting
      • 19.3.8. Application
      • 19.3.9. End User
      • 19.3.10. Country
        • 19.3.10.1. Turkey
        • 19.3.10.2. UAE
        • 19.3.10.3. Saudi Arabia
        • 19.3.10.4. Israel
        • 19.3.10.5. Rest of Middle East
    • 19.4. Turkey Medical Imaging AI Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Component
      • 19.4.3. Deployment Mode
      • 19.4.4. Imaging Modality
      • 19.4.5. Technology
      • 19.4.6. Workflow Stage
      • 19.4.7. Functionality
      • 19.4.8. Clinical Setting
      • 19.4.9. Application
      • 19.4.10. End User
    • 19.5. UAE Medical Imaging AI Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Component
      • 19.5.3. Deployment Mode
      • 19.5.4. Imaging Modality
      • 19.5.5. Technology
      • 19.5.6. Workflow Stage
      • 19.5.7. Functionality
      • 19.5.8. Clinical Setting
      • 19.5.9. Application
      • 19.5.10. End User
    • 19.6. Saudi Arabia Medical Imaging AI Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Component
      • 19.6.3. Deployment Mode
      • 19.6.4. Imaging Modality
      • 19.6.5. Technology
      • 19.6.6. Workflow Stage
      • 19.6.7. Functionality
      • 19.6.8. Clinical Setting
      • 19.6.9. Application
      • 19.6.10. End User
    • 19.7. Israel Medical Imaging AI Market
      • 19.7.1. Country Segmental Analysis
      • 19.7.2. Component
      • 19.7.3. Deployment Mode
      • 19.7.4. Imaging Modality
      • 19.7.5. Technology
      • 19.7.6. Workflow Stage
      • 19.7.7. Functionality
      • 19.7.8. Clinical Setting
      • 19.7.9. Application
      • 19.7.10. End User
    • 19.8. Rest of Middle East Medical Imaging AI Market
      • 19.8.1. Country Segmental Analysis
      • 19.8.2. Component
      • 19.8.3. Deployment Mode
      • 19.8.4. Imaging Modality
      • 19.8.5. Technology
      • 19.8.6. Workflow Stage
      • 19.8.7. Functionality
      • 19.8.8. Clinical Setting
      • 19.8.9. Application
      • 19.8.10. End User
  • 20. Africa Medical Imaging AI Market Analysis
    • 20.1. Key Segment Analysis
    • 20.2. Regional Snapshot
    • 20.3. Africa Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 20.3.1. Component
      • 20.3.2. Deployment Mode
      • 20.3.3. Imaging Modality
      • 20.3.4. Technology
      • 20.3.5. Workflow Stage
      • 20.3.6. Functionality
      • 20.3.7. Clinical Setting
      • 20.3.8. Application
      • 20.3.9. End User
      • 20.3.10. Country
        • 20.3.10.1. South Africa
        • 20.3.10.2. Egypt
        • 20.3.10.3. Nigeria
        • 20.3.10.4. Algeria
        • 20.3.10.5. Rest of Africa
    • 20.4. South Africa Medical Imaging AI Market
      • 20.4.1. Country Segmental Analysis
      • 20.4.2. Component
      • 20.4.3. Deployment Mode
      • 20.4.4. Imaging Modality
      • 20.4.5. Technology
      • 20.4.6. Workflow Stage
      • 20.4.7. Functionality
      • 20.4.8. Clinical Setting
      • 20.4.9. Application
      • 20.4.10. End User
    • 20.5. Egypt Medical Imaging AI Market
      • 20.5.1. Country Segmental Analysis
      • 20.5.2. Component
      • 20.5.3. Deployment Mode
      • 20.5.4. Imaging Modality
      • 20.5.5. Technology
      • 20.5.6. Workflow Stage
      • 20.5.7. Functionality
      • 20.5.8. Clinical Setting
      • 20.5.9. Application
      • 20.5.10. End User
    • 20.6. Nigeria Medical Imaging AI Market
      • 20.6.1. Country Segmental Analysis
      • 20.6.2. Component
      • 20.6.3. Deployment Mode
      • 20.6.4. Imaging Modality
      • 20.6.5. Technology
      • 20.6.6. Workflow Stage
      • 20.6.7. Functionality
      • 20.6.8. Clinical Setting
      • 20.6.9. Application
      • 20.6.10. End User
    • 20.7. Algeria Medical Imaging AI Market
      • 20.7.1. Country Segmental Analysis
      • 20.7.2. Component
      • 20.7.3. Deployment Mode
      • 20.7.4. Imaging Modality
      • 20.7.5. Technology
      • 20.7.6. Workflow Stage
      • 20.7.7. Functionality
      • 20.7.8. Clinical Setting
      • 20.7.9. Application
      • 20.7.10. End User
    • 20.8. Rest of Africa Medical Imaging AI Market
      • 20.8.1. Country Segmental Analysis
      • 20.8.2. Component
      • 20.8.3. Deployment Mode
      • 20.8.4. Imaging Modality
      • 20.8.5. Technology
      • 20.8.6. Workflow Stage
      • 20.8.7. Functionality
      • 20.8.8. Clinical Setting
      • 20.8.9. Application
      • 20.8.10. End User
  • 21. South America Medical Imaging AI Market Analysis
    • 21.1. Key Segment Analysis
    • 21.2. Regional Snapshot
    • 21.3. South America Medical Imaging AI Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 21.3.1. Component
      • 21.3.2. Deployment Mode
      • 21.3.3. Imaging Modality
      • 21.3.4. Technology
      • 21.3.5. Workflow Stage
      • 21.3.6. Functionality
      • 21.3.7. Clinical Setting
      • 21.3.8. Application
      • 21.3.9. End User
      • 21.3.10. Country
        • 21.3.10.1. Brazil
        • 21.3.10.2. Argentina
        • 21.3.10.3. Rest of South America
    • 21.4. Brazil Medical Imaging AI Market
      • 21.4.1. Country Segmental Analysis
      • 21.4.2. Component
      • 21.4.3. Deployment Mode
      • 21.4.4. Imaging Modality
      • 21.4.5. Technology
      • 21.4.6. Workflow Stage
      • 21.4.7. Functionality
      • 21.4.8. Clinical Setting
      • 21.4.9. Application
      • 21.4.10. End User
    • 21.5. Argentina Medical Imaging AI Market
      • 21.5.1. Country Segmental Analysis
      • 21.5.2. Component
      • 21.5.3. Deployment Mode
      • 21.5.4. Imaging Modality
      • 21.5.5. Technology
      • 21.5.6. Workflow Stage
      • 21.5.7. Functionality
      • 21.5.8. Clinical Setting
      • 21.5.9. Application
      • 21.5.10. End User
    • 21.6. Rest of South America Medical Imaging AI Market
      • 21.6.1. Country Segmental Analysis
      • 21.6.2. Component
      • 21.6.3. Deployment Mode
      • 21.6.4. Imaging Modality
      • 21.6.5. Technology
      • 21.6.6. Workflow Stage
      • 21.6.7. Functionality
      • 21.6.8. Clinical Setting
      • 21.6.9. Application
      • 21.6.10. End User
  • 22. Key Players/ Company Profile
    • 22.1. Aidoc
      • 22.1.1. Company Details/ Overview
      • 22.1.2. Company Financials
      • 22.1.3. Key Customers and Competitors
      • 22.1.4. Business/ Industry Portfolio
      • 22.1.5. Product Portfolio/ Specification Details
      • 22.1.6. Pricing Data
      • 22.1.7. Strategic Overview
      • 22.1.8. Recent Developments
    • 22.2. Arterys, Inc.
    • 22.3. Butterfly Network, Inc.
    • 22.4. Canon Medical Systems Corporation
    • 22.5. Digital Diagnostics Inc.
    • 22.6. Enlitic, Inc.
    • 22.7. GE HealthCare Technologies Inc.
    • 22.8. Google LLC
    • 22.9. HeartFlow, Inc.
    • 22.10. iCAD, Inc.
    • 22.11. Infervision
    • 22.12. International Business Machines Corporation (IBM)
    • 22.13. Koninklijke Philips N.V.
    • 22.14. Lunit Inc.
    • 22.15. Microsoft Corporation
    • 22.16. Qure.ai
    • 22.17. Siemens Healthineers AG
    • 22.18. Tempus AI, Inc.
    • 22.19. Viz.ai, Inc.
    • 22.20. Zebra Medical Vision
    • 22.21. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation